IDEXX Laboratories

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade IDEXX Laboratories 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About IDXX

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. 

CEO
Jonathan J. Mazelsky
CEOJonathan J. Mazelsky
Employees
11,000
Employees11,000
Headquarters
Westbrook, Maine
HeadquartersWestbrook, Maine
Founded
1983
Founded1983
Employees
11,000
Employees11,000

IDXX Key Statistics

Market cap
46.83B
Market cap46.83B
Price-Earnings ratio
45.06
Price-Earnings ratio45.06
Dividend yield
Dividend yield
Average volume
470.84K
Average volume470.84K
High today
High today
Low today
Low today
Open price
$582.48
Open price$582.48
Volume
0.00
Volume0.00
52 Week high
$769.98
52 Week high$769.98
52 Week low
$402.85
52 Week low$402.85

Stock Snapshot

The current IDEXX Laboratories(IDXX) stock price is $588.83, with a market capitalization of 46.83B. The stock trades at a price-to-earnings (P/E) ratio of 45.06.

IDEXX Laboratories(IDXX) stock opened on 2026-04-20 at $582.48. The price climbed to — and dipped to —.

The IDEXX Laboratories(IDXX)'s current trading volume is 0, compared to an average daily volume of 470.84K.

In the last year, IDEXX Laboratories(IDXX) shares hit a 52-week high of $769.98 and a 52-week low of $402.85.

In the last year, IDEXX Laboratories(IDXX) shares hit a 52-week high of $769.98 and a 52-week low of $402.85.

IDXX News

Simply Wall St 4d
Is It Too Late To Consider IDEXX Laboratories After Its 44% One Year Surge?

Wondering if IDEXX Laboratories at around US$580.76 a share still offers value, or if the best gains are already behind it? This article walks through what that...

Is It Too Late To Consider IDEXX Laboratories After Its 44% One Year Surge?
TipRanks 5d
Idexx Laboratories initiated with a Neutral at Citi

Citi analyst Daniel Grosslight initiated coverage of Idexx Laboratories (IDXX) with a Neutral rating and $650 price target The firm launched the animal health a...

Analyst ratings

67%

of 18 ratings
Buy
66.7%
Hold
27.8%
Sell
5.6%

People also own

Based on the portfolios of people who own IDXX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.